Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOPAT: Integrated Outpatient Treatment of Opioid Use Disorder and Severe Injection Related Infections
NCT04677114Phase 2Completed
- Start
- Mar 2021
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of buprenorphine extended-release injection in opioid use disorder (OUD), injection-related infection. Started Mar 2021; status: completed.
02
Drugs
buprenorphine extended-release injection
03
Conditions
opioid use disorder (OUD)injection-related infection
Beyond the preview
Go deeper on NCT04677114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04677114.